Instrumento Inactivo

Otros idiomas AEterna Zentaris Inc. Nasdaq

Acciones

CA0079753038

Precio de cierre Nasdaq Otros sitios de cotización
- ^USD	-

29/05	Las perdidas netas de Ceapro en el primer trimestre aumentan interanualmente, pero destaca los beneficios de la fusion prevista con Aeterna	MT
15/05	MT Newswires Canada Valores a vigilar durante la noche: Aeterna Zentaris; Orla Mining; Andlauer Healthcare; CES Energy Solutions; Imperial Metals; Sulliden	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Ceapro's Q1 Net Loss Swells YoY, But Talks Up Benefits of Planned Aeterna Merger	29/05
MT Newswires Canada Overnight Stocks To Watch: Aeterna Zentaris; Orla Mining; Andlauer Healthcare; CES Energy Solutions; Imperial Metals; Sulliden	15/05
Aeterna Zentaris Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Reverse Split: 1 for 4	03/05	FA
Aeterna Zentaris Reports Q4 Net Loss of US$5.6 Million, Provides DETECT Trial Update	27/03
Aeterna Zentaris Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Traders Search for Fresh Cues After Fed-Driven Rally as US Equity Futures Waver Pre-Bell	18/12
Top Premarket Gainers	18/12
Aeterna Zentaris and Ceapro Announce Merger of Equals to Create Diversified Biopharmaceutical Co	14/12
AETERNA ZENTARIS INC. : HC Wainwright maintient sa recommandation à l'achat	13/11
Aeterna Zentaris Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Aeterna Zentaris Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	09/08/23
Transcript : Aeterna Zentaris Inc. - Special Call	13/07/23
Aeterna Zentaris Inc. Provides an Update on Its Therapeutic and Diagnostic Development Pipeline Programs and Outlined Upcoming Key Milestones	13/07/23
AEterna Zentaris Reports Q1 Revenue of US$2.1 Million	09/05/23
Aeterna Zentaris Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	09/05/23
Aeterna Zentaris Inc. Provides Update on Macrilen(R) (Macimorelin) Reiterates Advancement of Pediatric DETECT Trial	05/04/23
Aeterna Zentaris Reports Q4 Net Loss of US$2.56 Per Share	23/03/23
Aeterna Zentaris Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23/03/23
Aeterna Zentaris Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23/03/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas AEterna Zentaris Inc. Nasdaq

Acciones

CA0079753038

Otros idiomas

Filtros